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Dear Editor,
A 21-year-old man presented with a rapidly growing (9 cm),
non-tender right flank mass with superficial excoriation and
inflammation (Fig. 1a). The lesion was accompanied by
rapid onset of disseminated brown papules, involving the
torso, back, and limbs (Fig. 1b). Facial and axillary skins
were spared, and there was no particular direction of spread.
The skin patches did not coalesce or show pruritus or
inflammation. There was also weight loss of 15 lb in
3 months. A positron emission tomogram scan (PET)
showed FDG uptake in the right waist (SUV 5.8) and right
groin (SUV 2.1) (Fig. 1c). Wide margin resection of the
mass and lymph node excision was performed with clear
margins. Histology of both specimens showed sheets and
loose clusters of pleomorphic malignant cells infiltrating the
dermis and subcutis with frequent mitosis (Fig. 1d). In view of
the anaplastic morphology and unusual presentation, exten-
sive immunophenotyping was performed. The cells were pos-
itive for CD1a, S100, and Langerin stains. They were negative
for melanocytic markers (HMB45, melan-A, MITF) EMA,
cytokeratin (CK, Cam 5.2, 34betaE12), actin, desmin, CD31,
CD34, c-kit, B and T markers (CD20, CD79a, CD3), CD68,
CD30, CD56, CD21, MPO, and ALK1. Electron microscopy
for Birbeck granules was not performed. The picture was
compatible with Langerhans cell sarcoma (LCS). A separate
skin biopsy of a pigmented lesion on the torso showed elon-
gated rete ridges with increased basal melanin pigmentation
within keratinocytes and the tips, with no increased Langer-
hans cells and no evidence of malignancy or dysplasia. The
lesion was compatible with common lentigo. The patient was
treated with consolidation radiotherapy to the primary sites,
but there was no regression of the skin lentiges.
In the World Health Organization classification, LCS is
the malignant end of the spectrum of benign Langerhans cell
histiocytosis (LCH) [1]. The typical LCH cell is replaced by
pleomorphic tumor cells in the LCS, only identifiable by
phenotype or ultrastructure. Initial unifocal subcutaneous
involvement is not unusual. However progressive disease,
especially with multifocal dissemination, is highly fatal,
despite multi-agent chemotherapy. It remains to be seen
whether systemic progression may occur in our patient.
Our patient demonstrated two hitherto unreported phe-
nomena, namely paraneoplastic manifestation of LCS and
acquired rampant disseminated lentigines as a new paraneo-
plastic dermatosis. The clinical history and histological find-
ings do not suggest an underlying disseminated cutaneous
LCH. Common paraneoplastic dermatoses (e.g., acanthocis
nigricans) are well characterized and are putatively caused
by neoplastic humoral secretions. Acquired melanocytic
nevi are mostly related to solar exposure and are therefore
localized. Recently, some cases of acral lentigines are debated
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to be paraneoplastic [2]. Disseminated lentigines are usually
only found in familial lentiginosis syndromes (e.g., LEOP-
ARD syndrome, Peutz–Jeghers, Carney complex, PTEN
hamartoma syndrome). The neoplastic associations of these
syndromes come from their primary systemic gene mutations
[3]. The rapidly acquired disseminated growth of lentigines in
our case is highly unusual and is somewhat induced by the
abnormal aggressive transformation of the LCS cells. Skin
pigmentation is usually under exquisite humoral control [4],
and cutaneous Langerhans cells interact closely with melano-
cytes and keratinocytes [5]. It is impossible, however, to
retrospectively work out the exact mechanism how the local-
ized growth induced a systemic pigment response, since in-
terval archival specimens are unavailable and the list of
possible mediators are extensive. In any case, extirpation of
the primary lesion appeared to halt further skin lesions.
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Fig. 1 a Clinical photo showing the flank mass with impending
ulceration. bWidespread lentiginous lesion all over the trunk heralding
the rapid growth of the malignant lesion. c PET with maximum
intensity projection showing two sites of active lesions in the flank
and in the right groin lymph node. d Histology of the lesion showing
sheets of pleomorphic tumor cells with indented or lobulated nuclei,
moderate to severe nuclear pleomorphism, distinct nucleoli, and
moderate pale eosinophilic or amphophilic cytoplasm. Occasional
multinucleated cells are present, and mitotic count is frequent. (H&E,
×400 magnification). e The tumor cells are positive for CD1a stain.
(Immunotech 1:20, ×400 magnification). f The tumor cells are positive
for Langerin stain with cytoplasmic granular staining. (Novocastra
1:200, ×400 magnification)
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